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Abstract
Background: In supervised learning, traditional approaches to building a classifier use two sets of
examples with pre-defined classes along with a learning algorithm. The main limitation of this
approach is that examples from both classes are required which might be infeasible in certain cases,
especially those dealing with biological data. Such is the case for membrane-binding peripheral
domains that play important roles in many biological processes, including cell signaling and
membrane trafficking by reversibly binding to membranes. For these domains, a well-defined
positive set is available with domains known to bind membrane along with a large unlabeled set of
domains whose membrane binding affinities have not been measured. The aforementioned
limitation can be addressed by a special class of semi-supervised machine learning called positive-
unlabeled (PU) learning that uses a positive set with a large unlabeled set.
Methods: In this study, we implement the first application of PU-learning to a protein function
prediction problem: identification of peripheral domains. PU-learning starts by identifying reliable
negative (RN) examples iteratively from the unlabeled set until convergence and builds a classifier
using the positive and the final RN set. A data set of 232 positive cases and ~3750 unlabeled ones
were used to construct and validate the protocol.
Results: Holdout evaluation of the protocol on a left-out positive set showed that the accuracy of
prediction reached up to 95% during two independent implementations.
Conclusion: These results suggest that our protocol can be used for predicting membrane-
binding properties of a wide variety of modular domains. Protocols like the one presented here
become particularly useful in the case of availability of information from one class only.
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Formally, a typical classification problem can be stated
as follows: given training data {(x1, y1), ...,(xn, yn)},
produce a classifier f: X Æ Y which maps an object x Œ X
to its classification label y Œ Y [1]. The xi values are
typically vectors of the form <xi,1 , xi,2 ,. . . ,xi, n>. Given
new x values, the classifier predicts the corresponding y
values. For example, if the problem is that of filtering
spam, then xi is some representation of an email (such as
the subject, body, etc.) and y is either “Spam” or “Non-
Spam”. This form of machine learning is called as
supervised learning where the aim is to establish a rule
whereby a new observation can be classified into one of
the existing known classes. Another class of machine
learning is the unsupervised learning where a set of
observations are given with the aim of establishing the
existence of classes or clusters in the data and the prior
distribution of the data is usually not known.
One of the limitations of supervised learning is that
examples or instances from both the classes are required
to build a classifier. Unavailability of sufficiently large
set of examples from both classes is quite often the case
with biological data due to various reasons: expenses
a n dt i m er e q u i r e dt oo b t a i nt h ed a t aa n do t h e r
experimental limitations. Instead of having examples
from both the classes, what is usually available is a
sizeable set from one class and a much larger number of
examples that are unlabeled.T h i si so n eo ft h em o s t
common occurrences in pharmaceutics and bioinfor-
matics. For example, usually there are only very few
inhibitors/drugs performing a certain function but a
much larger number of drugs that have not been tested
which would form the unlabeled set. This problem of
unavailability of well-annotated examples from both the
classes can be addressed by a special class of learning
called semi-supervised learning or partially supervised learn-
ing. A recently developed approach to execute semi-
supervised learning is the Positive-Unlabeled (PU) learning
[2,3] using two sets: a well-defined positive set, and a
much larger set with unlabeled examples. In this paper,
w ep r e s e n tt h ef i r s ti m p l e m e n t a t i o no fPU-learning
towards a bioinformatics problem: identification of
peripheral domains that bind various membranes
reversibly (Fig 1).
Peripheral proteins target different kinds of membranes
(cellular, nuclear etc) in response to certain signals.
These proteins, different from integral membrane pro-
teins, are mainly cytosolic (Figure 1) [4] and also play
crucial roles in membrane trafficking and in anchoring
cytoskeletal structures. Their reversible attachment to
biological membranes has been shown to regulate the
biochemistry of the cell through a variety of mechanisms
[5]. Many of these peripheral proteins have been directly
or indirectly involved with many deadly diseases like
cancer and AIDS [6,7]. In various kinds of human
cancers, a common signal is the overproduction of a
phospholipid, phosphatidylinositol (3,4,5) trisphos-
phate (PIP3), by the downstream action of AKT [6] that
is activated by an interaction between PIP3 and a very
common membrane-targeting domain called PH
domain[7]. Similarly, during the late phase of HIV type
1 (HIV-1) replication, newly synthesized retroviral Gag
proteins target the plasma membrane and interact with
another phospholipid, phosphatidylinositol (4,5)
bisphosphate (PIP2), an event that is essential for viral
replication and pathogenesis [8]. Thus, the medical and
molecular importance of these domains and their host-
proteins is well established.
Structural biology has deciphered the structural basis of
specific lipid binding and membrane interactions of
membrane targeting domains and peripheral proteins.
However, it would be prohibitively time-consuming and
expensive to search and identify new peripheral proteins
on a genomic-scale by these experimental approaches.
Therefore, a fast and accurate bioinformatics-based
annotation scheme would greatly supplement the effort
to identify membrane-binding peripheral proteins on a
genomic scale.
Figure 1
An example of the peripheral domain (C2-domain of
PKCa,P D BI D :1DSY). The protein targets specific lipids
in the membranes in response to certain signal which, in this
case, is binding of 2 Ca
2+ ions (shown as red spheres). The
protein (shown in cartoon representation) penetrates the
membrane partially. Lipid hydrogens are not shown for
clarity.
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gaining speed, it will still take many years before 3D
structures of most proteins in the proteome of com-
monly studied organisms become available. So, for
genome-wide prediction of peripheral proteins the
need for sequence-based prediction protocols that
don’t rely on structures and can give reasonable
precursor performance becomes inevitable. Here we
broaden the prediction of peripheral proteins to that
based on the features derived from their sequences alone
to advance in the direction of whole-genome prediction.
In case of peripheral domains, there is a well defined set
of domains which are known to bind the membranes
with different affinities. However, there is a much larger
set of proteins whose affinities have not been measured.
So, there is no such fairly large dataset for the proteins
that are known not to bind membrane.O n eo ft h e
common criteria for constructing a negative set is the
subcellular localization. For example, the proteins that
reside in the cytosol can not perform the DNA-binding
function. However, this criteria can not be applied in this
case as membranes confine many organelles of the cell
(nucleus, mitochondria, the cell itself) and can be
accessed anywhere. So, there is no golden negative set
of proteins that are known not to bind membrane, thus
standard supervised learning can not be applied here
directly. So, here in this paper, we address this problem
with the first bioinformatics application of PU-learning
to identify peripheral domains based on their sequence-
derived properties. We will show that PU-learning in
combination with other auxiliary binary classification
algorithms can be effectively used to build an identifica-
tion protocol for predicting the membrane binding
properties of a large number of modular domains with
unknown properties.
Previously, there have been attempts to identify peri-
pheral proteins using machine learning [9,10] that
achieved an accuracy of about 90%. However, one
major difference between those works and this study is
that they were based on structural features of the
proteins and so were based on a much smaller set of
about 40 proteins with 3D structures. The negative set in
those studies was also a high confidence one as those
structures were well studied and annotated. In this study,
on the other hand, we do not require structure of the
proteins and use only sequence based descriptors so we
have a much larger positive set and a poorly annotated
negative set.
Methods
In simple words, the machine learning problem being
addressed here can be stated as: given a set of membrane-
binding proteins, can we identify other membrane-
binding proteins from a larger unlabeled set while
classifying the proteins in the unlabeled set as positive
or negative? The main components of the classification
process are feature development, classifiers, validation
techniques and performance criteria which are discussed
below after explaining PU-learning in detail.
Theory behind PU-learning
PU-learning attempts to build a classifier using a two
step-strategy [2,3] (Figure 2):
Step 1: Identifying a set of reliable negative examples
from the unlabeled set.
Step 2: Building a set of classifiers by iteratively applying
a classification algorithm and then selecting a good
classifier from the set.
These two steps together can be seen as an iterative
method of increasing the number of unlabeled examples
that are classified as negative while maintaining the
number of correctly classified positive examples. There
are a couple of techniques proposed for each step. For
the first step, Rocchio technique, the Spy technique, and
the 1-DNF technique can be used. For the second step,
any classifier, such as SVM, Bayes classifier, random
forest or decision trees can be used. For the focus of this
article, only the spy-technique is explained in great
details. The readers are directed to relevant literature
[2,3] for details about the other techniques regarding the
first step.
Figure 2
Two step strategy used in Positive-Unlabeled learning.
In the first step, a set of reliable negative examples are
identified using a spy technique. During the spy technique,
some positive examples are included in the U set as spies.
After the classification, a threshold is chosen such that all the
spies are classified as positive and the ones below the
threshold form the reliable negative (RN) set. In the second
step, the RN set and the P set are used to build a classifier.
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(called the P set) are sent to the mixed or unlabeled set
(called the U set) (Figure 3). This approach randomly
selectss%oftheexamplesfromthePset(inourexperiment,
we use 15%). These examples form the ‘spies’ set, denoted
by S, which is added to the U set. The spies behave
identically to the unknown positive examples in U and
hence allow us to reliably infer the behavior of the
unknown positive examples. The algorithm is as follows:
1. N = ￿
2. S = sample (P, s%)
3. U = U ∪ S
4. P = P - S
5. Assign every example in P the class c1
6. Assign every example in U the class c2
7. Run any classifier
8. Classify each example in U
9. Determine the probability threshold t using S
10. for each example dj in U
11. if its probability Pr [c1|dj] < t
12. RN = RN ∪ {dj}
13. U = U - {dj}
14. Repeat steps 7 to 13 with RN and U until RN does
not change
The first classifier is built using the P set (after removal of
spies) as positive set and the U + S (spies set) as the
negative set. This classifier is then tested on the U+S set.
A threshold is then determined such that all the spies are
classified as positive. The unlabeled examples that are
below that threshold form the first reliable negative
(RN1) set and the remaining examples in U form the Q1
set. The process is then repeated with P (combined with
S set) as positive and the reliable negative (RN)s e ta s
negative and the resultant classifier is tested on the Q set
to further extract reliable negative examples from the Q
set. The process above is repeated until no more
examples in the Q set can be classified as negative. The
final classifier is then built using the N and the original
P set. The pseudo code is as follows:
E v e r ye x a m p l ei nPi sa s s i g n e dt h ec l a s sl a b e l1 ;
Every example in RN is assigned the class label -1;
i=1 ;
Loop
Use P and RN to train a classifier Si;
Classify Q using Si;
Let the set of examples in Q classified as negative be
W
if W = {} then exit-loop
e l s eQ=Q-W ;
RN = RN ∪ W;
i=i + 1 ;
In this article, we also propose and implement a variation
of the spy-technique. The spies are added in each
iteration as opposed to just the first iteration [3]. Figure 4
shows this technique in a cartoon representation.
So, PU-learning adds an additional layer to the standard
supervised learning. In this layer the first set of reliable
negative examples is created. Using this reliable negative
s e ta n dt h eo r i g i n a lp o s i t i v es e t ,m o r er e l i a b l en e g a t i v e
examples are extracted in the subsequent steps using a
classifier iteratively. For this study, spy-technique was
used for the first step and random forests were used for
the second step. As we will show, the PU-learning
protocol with spy-technique can be effectively used to
build an identification protocol for predicting the
membrane binding properties of a large number of
modular domains with unknown properties.
Dataset
For the creation of positive dataset, entire human, mouse
and yeast proteomes were downloaded from the Swiss-
Prot database [11]. All the sequences of the peripheral
domains were then extracted by using their names as
keywords resulting in 932 cases. The known domains
include C1, C2, PH, PX, FYVE, ANTH, BAR, FERM and
Tubby domains. Sequence identity was then reduced to
40% using CD-HIT [12] among all the pairs reducing the
number of sequences to 232. For unlabeled set, all the
other domains except the positive ones were selected
from the three proteomes giving a total of approximately
32,000 examples. After reducing the sequence identity to
20%, the number of unlabeled examples was 3,759.
Figure 3
The spy technique. Figure 4
Modified spy technique.
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as the number of positive examples is few and using a
lower sequence identity would result in much fewer
examples that might be insufficient for building a
reliable classification model.
Features
During feature development, a protein sequence is
reduced to a fixed set of features encoding the
characteristics of a protein. It is always advisable to
choose the features that are supposed to be pertinent to
the function of a protein and display large variation
between positive and negative set.
All intracellular membranes contain varying degrees of
anionic lipids with the inner plasma membrane being
the most anionic [13,14]. Thus, electrostatic comple-
mentarity between cationic proteins and anionic mem-
branes should be an important factor in membrane
binding of peripheral proteins. Thus, on the basis of
previous studies on membrane binding proteins, various
sequence-based features were selected: the overall charge
of the protein; the sum of hydrophobicity, helix
propensity and sheet propensity; and the overall
sequence composition of the domain (% of each kind
of amino acid). In addition, a new family of features
called local environment amino acid composition is also
used. This feature representation defines a residue based
on both its identity and its environment of found kinds:
low helix and high sheet propensity, high helix and low
sheet propensity, and so on. This forms 80 (4 × 20)
distinct counts in the new feature vector.
Performance criteria and evaluation technique
The performance of the classifiers is measured using
different metrics. Specifically, the commonly-used
threshold metrics include accuracy and sensitivity.
Accuracy is the ratio of correct predictions to the total
number of predictions.
Accuracy
TP TN
TP FP TN FN
=
+
++ +
(1)
Sensitivity, also known as recall or true positive rate,
TPR, is defined as the probability that a prediction is
predicted positive given the example is positive. It is
approximated by the fraction of true positives predicted
as positive.
Sensitivity
TP
TP FN
=
+
(2)
For evaluating the performance of the protocol, the
holdout technique was used during testing. During this
evaluation, 40 positive examples were left out for testing
the final classification protocol. These examples were not
used for training purposes at any stage of the model
building. Due to an uncertainty about their classes, no
examples from the unlabeled set were left out for testing
a n ds oo n l ys e n s i t i v i t yw a su s e df o rp e r f o r m a n c e
evaluation. During training, 5-fold cross-validation was
used to optimize the parameters.
Classifier
Decision trees, specifically, C4.5 was used as a classifier.
A decision tree [15] constructs from the training data
a tree model where every internal node represents
a decision and a leaf represents its classification. The
learning process starts by finding a split on a single
attribute that best classifies the training data; then the
dataset is recursively split into two parts repeating these
steps on each subset. There are a number of loss (or
impurity) functions that are used to find the best split or
the split with the minimum loss (or error). Specifically,
the C4.5 [16] decision tree algorithm developed by
Quinlan uses a loss function known as the information
gain, which is motivated by information theory. The
decision tree has several advantages. First, it is fast to
train and evaluate. Second, the model (or function)
learned during the training process is usually compact
and easy to interpret. Finally, a decision tree does not
require much data preprocessing, natively handling most
attributes types. Note, most machine learning algorithms
have tunable parameters. In this work, the results
reported using the C4.5 decision tree algorithm use the
default values empirically found to work well on a
number of datasets.
Results
During the initial iteration, the first reliable negative set
is created by the examples that were classified as negative
(those that fell below the threshold of the spies) from
the unlabeled set and the remaining unlabeled data form
the Q (= U-RN1) set. In subsequent iterations, some
examples from the Q set are identified as reliable
negative and are added to the RN set. Thus, the RN set
keeps expanding with the addition of more proteins
from the unlabeled set while the Q set keeps shrinking.
This process is repeated until no examples from the Q set
can further be classified as negative.
We selected 30 positive examples (approximately 15% of
total 232 positive cases) and added them to the
unlabeled set as spies carrying a negative label (U+S).
The U+S s e ta n dt h er e m a i n i n g2 0 2p o s i t i v ec a s e sw e r e
then used to build the first binary classification protocol
that was tested on the U+S set. Based on the threshold so
that all the spies are classified as positive, 877 examples
were identified from the U set as reliable negative
BMC Bioinformatics 2010, 11(Suppl 1):S6 http://www.biomedcentral.com/1471-2105/11/S1/S6
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positive examples, more reliable examples were extracted
from the Q set until no more examples in Q could be
classified as negative. Figure 5 shows the growth of the
reliable negative set and the shrinking of the Q (= U-RN)
set. After 10 iterations, both RN and Q set converged at
2,031 and 1,728 examples.
This final model built in the last iteration was then used
to classify each example in the holdout set composed of
40 positive examples. 38 of these 40 examples were
classified as positive and only 2 were classified as
negative giving an accuracy of 95% with a sensitivity of
95%. When compared with the fraction of Q,w h i c hi s
only 46% of the total dataset, this 95% sensitivity in
testing set shows that the classification protocol learnt to
identify the positive examples with a high accuracy.
Another variation of the spy technique was also tried: the
spies were added during each iteration as opposed to just
the first iteration implemented before. Figure 4 shows
this technique in a cartoon representation. Similar
procedure as above was then performed for this spy
technique. Similar to the first implementation, with each
iteration, RN set grows and Q set shrinks until
convergence. Figure 6 shows the trend of the two set as
a function of iteration. The protocol converged with the
same set of RN examples as in the first implementation
increasing the confidence in this set. With this modifi-
cation of the spy technique, the performance of the
protocol was evaluated, as above, by testing the final
model on the holdout test of 40 proteins. Similar to the
first case, 38 domains were correctly classified and only
2 were incorrectly classified giving an accuracy of 95%
and a similar sensitivity. The two proteins that were
misclassified were the same misclassified proteins as in
the first implementation: Protein pob1 and Oxysterol-
binding protein 1. Upon further examination, we found
that these proteins have very dissimilar characteristics
such as amino acid and dipeptide composition to other
positive cases. This is also demonstrated by the fact that
both these proteins share less than 15% and 16%
sequence identity, respectively, with any other sequence
in the set. Performances of both the protocols show their
potential for genome-scale identification of peripheral
domains.
Discussion
One of the common issues in building machine learning
based classifiers is the unavailability of reasonably large
sets of examples from both (or all) the classes in case of
binary (or multi) class problems. This problem of having
partial information is all the more encountered in
biological fields where collection of data may not be
an easy task. So, what is usually available is a set of
examples belonging to one of the two classes and a much
larger set of unlabeled examples that might belong to
either class. The task of building a classifier with this
partial information then falls under semi-supervised
learning and can be accomplished through Positive-
Unlabeled learning.
Here in this article, we implemented a classification
protocol that represents the first attempt to identify and
predict membrane-binding domains on the basis of their
sequence-derived features using positive-unlabeled learn-
ing. The application of PU learning surpasses the
unavailability of a well-define negative set consisting of
Figure 5
Reliable negative (RN)a n dt h eQ (= U-RN)s e t sa sa
function of iteration with the spy technique.
Figure 6
Reliable negative (RN)a n dt h eQ (= U-RN)s e t sa sa
function of iteration with the modified spy technique.
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the best of our knowledge, the first application of PU-
learning to any bioinformatics problem. Prior to this
work, it has only been applied to text classification of
web pages [2,3].
We have used simple sequence-derived features of
known peripheral proteins to identify other putative
membrane-binding proteins also proposed a list of other
proteins that, we believe, are highly unlikely to bind
membranes. Simple sequence-derived features are used
to build the protocol. Two independent tests demon-
strate that the developed protocol can identify peripheral
domains with a high accuracy. In both the tests, accuracy
achieved was 95% whereas a similar sensitivity was
registered. These results combined with the fact that this
protocol only uses sequence-derived features without
actually depending on sequence homology suggest that
our protocol can be used to predict the membrane-
binding properties of modular domains, including other
membrane targeting domains, with high accuracy. For
those proteins without modular domains and homology
to known proteins, our protocol can serve as initial
screening for potential candidates.
In this article, we also propose a modified spy technique
where the spies are added to the unlabeled set in each
iteration instead of just the first one. Each time, a randomly
selected spy set is added that makes the protocol more
robust. When the Q set converges even after adding a new
set of spies during each iteration, it renders more
confidence in the final reliable negative (RN) set. Also,
the fact that the final RN set was the same in both
implementations (original and modified spy technique)
also boosts the reliability of the protocol’sp r e d i c t i o n .
As an output of this protocol, we have proposed two sets:
a set of proteins that are most unlikely to bind membranes
(final RN set) of ~2000 proteins and the remaining Q set of
~1700 proteins that can not be classified clearly in either
class. Proteins belonging to both RN and Q set were picked
by the protocol from the initial unlabeled set of ~3700 set.
So, essentially, we have reduced the number of proteins
which are expected to bind membranes to a representative
set of ~1700 which would provide a good initial list of
proteins to test experimentally for their membrane binding
properties for a genome-wide identification of membrane-
binding proteins. Efforts and collaborations are underway
to test the Q set to test for their membrane-binding
properties (Professors Wonhwa Cho and Robert Stahelin,
personal communication).
It should be noted here that a limitation of the method
employed above, and of generative machine learning in
general, is that it identify new instances on the basis of
features learnt from training examples; identification of
novel instances that are not similar to any the training
instances is difficult. This is particularly the case for
peripheral proteins as they use a variety of features to
target membranes. So, to partially overcome this limita-
tion, we introduce as much variety in our training/spy set
as possible with the given data by using a modified
version of PU learning where we randomly use a new spy
set in each iteration.
Conclusion
In this work we applied PU learning to a protein
function prediction problem: identifying membrane
binding domains. Encouragingly, the high accuracy
prediction (at 95%) of the holdout set share very low
sequence identity with the training set; 50% of the pairs
between these sets have only 6% identity and all the
pairs were less than 20% identical. These identities are
much lower than the limit for identifying similar cases
based on homology searches. This shows that PU
method performs better than just identifying novel
instances based on sequence homology.
In general, the above protocol can be applied to any
bioinformatics problem where a similar issue is encoun-
tered. For example, this protocol will especially prove
useful in problems like prediction of protein-protein
interactions (where a golden negative set of proteins that
are known not to interact with each other is not available)
and quantitative structure-activity relationship (QSAR)
studies where information about the negative set of
proteins not related with a biological or chemical activity
is highly scarce. We believe in present times when our
knowledge is limited and ever-increasing, protocols like
the one presented in this article that can make use of
only partial information will prove to be very useful.
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